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Evidence supports the existence of an association between dyslipidemia, psychiatric
disorders, and suicide risk due to the effects of altered lipid profiles on serotoninergic
neuron membranes. The aim of this study was to investigate the differences in c-reactive
protein (CRP), thyroid functioning, total cholesterol, high lipoprotein density cholesterol
(HDL-c), low-lipoprotein density cholesterol (LDL-c), and triglycerides (TG) serum levels in
low lethality (LLSA) vs. high lethality suicide attempters (HLSA) within 24 h from the suicide
attempt and inpatients who never attempted suicide (NAS). After attempting suicide,
subjects were admitted to the emergency ward of the IRCCS Ospedale Policlinico
San Martino and later to the section of Psychiatry from 1st August 2013 to 31st July
2018. Socio-demographic and clinical characteristics, serum lipids profile, CRP, and
thyroid functioning were collected. The sample consisted of 133 individuals with a HLSA,
299 subjects with LLSA, and 200 patients NAS. HLSA subjects were more likely to
be males and diagnosed as having a bipolar disorder. Furthermore, HLSA subgroup
showed significantly lower total cholesterol and LDL-c levels and higher CRP serum
levels compared to LLSA and control group, respectively. LLSA subgroup showed
higher HDL-c levels compared to HLSA subgroup (no differences between HLSA and
control group were observed). Additionally, the control group reported higher triglycerides
levels compared to patients admitted to psychiatric ward for a suicide attempt. Only
male gender, having a diagnosis of bipolar disorder, lower total cholesterol, and higher
CRP serum levels predicted HLSA. Investigating the relation between dyslipidemia and
the severity of suicide attempts may contribute to reveal the complex determinants
underlying at-risk behaviors such as suicide, thus playing a relevant role in the possible
prevention of this disabling phenomenon.
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INTRODUCTION
Suicide and non-fatal suicidal behaviors are major causes of mortality and morbidity worldwide.
TheWorld Health Organization (1) estimated that∼800,000 people die from suicide each year and
a number from 10 to 20 times higher of individuals attempt suicide, indicating that both suicide and
non-fatal suicidal behaviors need to be addressed as a real health priority. The variability in rates
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of suicidal behaviors within and between countries has been
attributed to both population and individual risk factors,
including economic status and cultural differences (2) that may
significantly affect suicide risk.
Different explanatory models were developed in order to
reveal the complex interplay between neurobiological factors
such as genetic risk variables, altered serotonergic functioning,
and stress responses potentially leading to suicidal behaviors
(3, 4). Interestingly, two major dietary lipid classes, cholesterol,
and polyunsaturated fatty acids (PUFAs), were significantly
associated with higher suicide risk (5, 6). Consistent with
the inflammation-related hypothesis of depression and suicidal
behavior, C-reactive protein (CRP) blood levels were directly
associated with the enhanced risk of attempting and committing
suicide (7–9), suggesting that CRP may be a trait marker of
suicidal behavior due to its pro-inflammatory effect together
with its growing levels during acute inflammation (10). From
a genetic perspective, genome-wide association studies (GWAS)
identified a region on 2p25 that influences risk for attempting
suicide and contains the ACP1 gene (11, 12) and polymorphisms
in ACP1 which were found to modulate both protection and
predisposition to dyslipidemia (13).
The association between low total cholesterol and cholesterol
metabolites serum levels with higher suicide risk has been
reported since 1990, when Muldoon et al. initially showed
that treatments able to reduce cholesterol levels may attenuate
the excess of suicidal behaviors and injury deaths in their
sample (14). These results were confirmed by a wide body of
literature showing significant associations between altered lipid
profiles and higher suicide risk both in patients with specific
psychiatric disorders as well as in non-clinical populations (15–
21). Recently, Wu et al. conducted a large meta-analysis on
65 epidemiological studies, involving 510.392 participants, and
investigated the association between serum lipid levels and
“suicidality” subjects defined as individuals presenting suicidal
ideation, suicide attempt, having threatened suicide, or death by
suicide. Their findings showed that total cholesterol (TC) and
low density lipoprotein cholesterol (LDL-c) levels were lower in
suicidal patients than non-suicidal patients and healthy controls,
high density lipoprotein cholesterol (HDL-c) levels were lower
in suicidal patients relative to healthy controls, and triglycerides
(TG) levels were lower in suicidal when compared to non-suicidal
patients, respectively. Importantly, when the three groups were
pooled, lower serum TC was associated with a 112% higher risk
of suicidal behaviors (22).
Moreover, subjects who attempted suicide within a month
from the blood tests had significantly lower TG and higher
HDL-c levels than lifetime suicide attempters and those who
never attempted suicide, with TG levels that were negatively
associated with current suicidal behavior (23). However, other
studies investigating a sample of inpatients with type 1 bipolar
disorder and other psychiatric conditions failed to confirm these
findings reporting no significant differences in lipid profiles
between suicidal and non-suicidal subjects (24–26).
Recent studies investigated the role of cholesterol levels
in violent vs. non-violent suicide attempts and showed that
the former was significantly associated with lower cholesterol
serum levels of ∼30% than the latter (27–29). Moreover,
two post-mortem studies showed significantly lower cholesterol
levels in the pre-frontal-cortex (PFC) of violent suicide
attempters and significantly higher cholesteryl-ester-hydrolase
(LIPA) expression in violent suicide attempters when compared
with non-violent suicide attempters (30, 31).
Given this background, in this study we investigated the
differences in CRP, thyroid functioning, TC, HDL-c, LDL-c, and
TG serum levels between low-lethality (LLSA) vs. high-lethality
suicide attempts (HLSA) within 24 h from the suicide attempt
and inpatients who never attempted suicide (NAS).
According to this main objective, we tested the following
hypothesis: (a) lower total cholesterol, HDL-c, LDL-c, and
TG serum levels determine HLSA instead of LLSA and
NAS; (b) CRP levels are higher in HLSA instead of LLSA
and NAS.
MATERIALS AND METHODS
Sample
The present study was conducted in a sample of patients who
were recruited at the section of Psychiatry of the IRCCS Ospedale
Policlinico San Martino—Department of Neuroscience,
Rehabilitation, Ophthalmology, Genetics, Maternal, and Child
Health, University of Genoa, Italy, from 1st August 2013 to 31st
July 2018.
The inclusion criteria were: (a) hospitalization in an
emergency psychiatric ward for a suicide attempt; (b) aged over
18 years old; (c) the willingness to participate in the study by
signing a written informed consent. The exclusion criteria were:
(a) pregnancy or having just given birth; (b) having a positive
history of acute neurological injury, such as neurodegenerative
illnesses, mental retardation, loss of consciousness related to the
presence of severe neurological conditions; (c) the assumption of
lipid-lowering agents; (d) the refusal or inability to provide a valid
consent prior to participate in the study.
A control group was also included in the sample and it was
represented by admitted patients without a history of current
and/or lifetime suicide attempts. The control group was matched
for age, gender, occupational/marital status, and diagnosis to
avoid any bias. We initially screened a sample of 703 patients;
however, only 632 subjects voluntarily accepted to participate in
the study by signing a written informed consent, the remaining
individuals were lost due to lack of serum data or because they
did not sign the required informed consent.
The study design was reviewed and approved by the local
ethic committee.
Assessments and Procedures
Socio-demographic and clinical characteristics of the recruited
patients were investigated during hospitalization through the
standardized clinical chart and lifetime computerized medical
record, used in Psychiatric Unit. The following patients’ domains:
age, gender, marital and occupational status, education level,
suicide attempts, and suicide method were carefully investigated.
All available information have been cross-referred.
Psychiatric diagnoses were evaluated and set according to
Diagnostic and Statistical Manual of Mental Disorders, fifth
edition (DSM 5) (32). Clinical evaluations were carried out by
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expert clinicians and carefully reviewed by a senior psychiatrist
(with at least 10 years of clinical experience in inpatient
clinical setting). If patients had more than one psychiatric
diagnosis, the principal psychiatric condition as diagnosed by
the treating psychiatrist, was recorded. According to previous
published studies (33, 34), we grouped the diagnosis in four main
categories: bipolar and related disorders, depressive disorders,
schizophrenia, and related disorders, other psychiatric disorders.
Based on Schrijvers et al., we considered suicide as a process,
for which suicidal behaviors can be broken down chronologically
into “component parts,” beginning with the development of
suicidal ideation, that progresses to planning, then putting
thoughts and plans into action via attempts, and, if successful,
culminating in completed suicide (35).
The term “suicidal lethality” has not yet been defined outside
health literature. Beyond one publication describing suicide
lethality as the lethality of the chosen suicide method (36),
some theorists like Shneidman and Joiner conceptually identified
suicide lethality “as a key ingredient of serious suicidality”
(37, 38). We adopted Joiner’s definition of suicide lethality,
defined as “the acquired ability to enact lethal self-injury” (38).
Within suicide lethality, the only individual intent is to perish
as a result of the lethality of self-inflicted actions. Methods
of suicide attempt were dichotomized in terms of lethality.
Therefore, a high-lethality suicide attempt was defined as a
suicide attempt that warranted hospitalization for at least 24 h
and either treatment in a specialized unit (including intensive
care unit, hyperbaric unit, or burn unit), surgery under general
anesthesia, or extensive medical treatment (beyond gastric
lavage, activated charcoal, or routine neurological observations),
including antidotes for drug overdoses, telemetry, or repeated
tests or investigations. Conversely, a low-lethality suicide attempt
was defined as a suicide attempt that did not meet these
criteria (39–46).
A routine blood examination was usually performed at
hospital admission for all patients as a part of the clinical
management routine. Blood samples were taken between 7:00
and 8:30 a.m. after patients had fasted for at least 10 h and after
a psychiatric evaluation; patients who were not fasting were
rescheduled. Blood exams included TC, TG, HDL-c, LDL-c, CRP
serum levels, and TSH Reflex. Blood samples were drawn during
the hospitalization in the Psychiatric Clinic and examined in the
laboratory analysis of IRCCS Ospedale Policlinico San Martino,
Genoa, Italy.
Statistical Analysis
All statistical analyses were performed using SPSS version 22.0
(IBM Corp., Armonk, NY, USA) with the value of statistical
significance which was set at p < 0.05.
Socio-demographic and clinical characteristics of the subjects
were represented as mean and standard deviation (SD)
for continuous variables and as frequency and percentage
regarding categorical variables. The Kolmogorov-Smirnov test
was conducted to confirm whether all the investigated sample
variables followed the normal distribution.
Firstly, the sample was divided in two subgroups according
to the presence/absence of current suicide attempt. A statistical
comparison between patients with and without current suicide
attempt was performed to examine whether there were
differences in terms of socio-demographic and diagnostic
features. Thus, in order to avoid statistical bias, the two
subgroups were matched for age, gender, marital/occupational
status, and psychiatric diagnoses.
Subsequently, the subgroup of patients admitted for a
current suicide attempt was divided according to the lethality
of suicide attempts, identifying a subgroup with high-lethality
of suicide attempts and a subgroup with low-lethality of suicide
attempts. In order to analyze differences between these three
subgroups, we used the Pearson χ2 test with Yates correction
for the comparison of categorical variables, and ANOVA for
continuous variables.
Lastly, a multinomial regression model was performed to
detect the variables associated with the lethality of suicide
attempt (dependent variable) and each of the other independent
variables previously found associated in the statistical analyses.
The probability of entering the equation was set at 0.05.
RESULTS
In our study we recruited a total sample of 632 patients, with
a mean age of 49.69 ± 18.97 years old. Of the total sample,
478 subjects were females (75.6%) with an educational level of
11.06 ± 3.28 years. Four hundred and thirty-two subjects were
recruited in the case-group and 200 in the control group. There
were no statistically significant differences in socio-demographic
and clinical characteristics (i.e., gender, age, marital status,
educational level, working status, psychiatric diagnoses and
pharmacological treatment) between the subgroup of patients
who attempted suicide and the subgroup of patients who
never attempted suicide (control group). Socio-demographic and
clinical characteristics of the included subjects are summarized in
Tables 1, 2.
Regarding patients admitted for a suicide attempt, 133
individuals (30.8%) committed a HLSA while 299 subjects
(69.2%) carried out a LLSA, respectively. The prevalence of the
method used to attempt suicide is shown in Table 3.
Considering socio-demographic and clinical features within
the three subgroups, the HLSA subgroup was significantly
associated with male gender (38.3 vs. 16.1 vs. 27.5%, p < 0.001)
and diagnosis of bipolar disorder (41.4 vs. 29.1 vs. 32.0%,
p= 0.007), compared to LLSA, and control group, respectively.
When the three subgroups were compared, the HLSA
subgroup showed significantly lower total cholesterol levels
(151.08± 40.90 vs. 184.40± 43.21 vs. 189.41± 33.88, p < 0.001)
and LDL-c levels (99.55 ± 33.25 vs. 119.15 ± 38.30 vs. 126.15 ±
31.52, p< 0.001), and higher CRP serum levels (24.18± 38.69 vs.
8.78 ± 19.66 vs. 4.37 ± 5.61, p < 0.001) compared to LLSA and
control group, respectively.
Furthermore, the LLSA subgroup showed higher HDL-c levels
compared to HLSA subgroup (54.64 ± 16.59 vs. 46.31 ± 17.82,
p < 0.001) (no differences between HLSA and control group
were observed). Additionally, the control group reported higher
triglycerides level compared to patients admitted for a suicide
attempt. No differences in triglycerides levels between HLSA and
LLSA were found). Additional differences are shown in Table 4.
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TABLE 1 | Socio-demographic characteristics in the total sample and in the two subgroups.
Total sample
(N = 632)
Suicide
attempt
(N = 432)
No suicide
attempt
(N = 200)
t/χ2 df p
Gender (female), N (%) 478 (75.6) 333 (77.1) 145 (72.5) 1.558 1 0.212
Age (years), mean ± SD 49.69 ± 18.97 49.13 ± 20.16 50.89 ± 16.11 1.086 630 0.278
Education level, mean ± SD 11.06 ± 3.28 11.15 ± 3.27 10.86 ± 3.30 −1.046 630 0.296
MARITAL STATUS, N (%)
Single 296 (46.8) 195 (45.1) 101 (50.5) 4.672 3 0.197
Married 131 (20.7) 93 (21.5) 38 (19.0)
Divorced 147 (23.3) 98 (22.7) 49 (24.5)
Widowed 58 (9.2) 46 (10.6) 12 (6.0)
Working status, N (%) 177 (28.0) 121 (28.0) 56 (28.0) 0.000 1 0.998
TABLE 2 | Clinical characteristics in the total sample and in the two subgroups.
Total sample
(N = 632)
Suicide
attempt
(N = 432)
No suicide
attempt
(N = 200)
t/χ2 df p
DIAGNOSIS, N (%)
Bipolar and related disorders 206 (32.6) 142 (32.9) 64 (32.0) 4.434 3 0.218
Schizophrenia and related disorders 63 (10.0) 37 (8.6) 26 (13.0)
Depressive disorders 202 (32.0) 146 (33.8) 56 (28.0)
Others 161 (25.4) 107 (24.7) 54 (27.0)
PHARMACOLOGICAL TREATMENT, N (%)
Antipsychotics 252 (58.3) 175 (40.5) 77 (38.5) 0.230 1 0.631
Mood stabilizers 303 (70.1) 202 (46.8) 101 (50.5) 0.766 1 0.381
Antidepressants 165 (38.2) 110 (25.5) 55 (27.5) 0.294 1 0.588
Others 108 (25.0) 82 (19.0) 26 (13.0) 3.452 1 0.063
Drug-free 55 (12.7) 40 (9.3) 15 (7.5) 0.533 1 0.466
Total Cholesterol, mean ± SD 178.97 ± 42.50 174.14 ± 45.17 189.41 ± 33.86 4.257 630 <0.001
LDL Cholesterol, mean ± SD 117.23 ± 36.47 113.11 ± 37.88 126.15 ± 31.52 4.235 630 <0.001
HDL Cholesterol, mean ± SD 51.55 ± 17.11 52.08 ± 17.39 50.43 ± 16.50 −1.128 630 0.260
Tryglicerides, mean ± SD 122.63 ± 69.07 114.32 ± 57.38 140.58 ± 86.73 4.514 630 <0.001
TSH reflex, mean ± SD 2.33 ± 1.92 2.30 ± 1.89 2.40 ± 1.99 0.629 630 0.529
CRP, mean ± SD 10.63 ± 23.63 13.52 ± 27.86 4.37 ± 5.61 −4.599 630 <0.001
When the multinomial regression was performed, male
gender, diagnosis of bipolar disorder, lower total cholesterol level,
and higher CRP serum levels predicted HLSA (Table 5).
DISCUSSION
The present study tested the association between lipid profile,
CRP levels, and thyroid functioning in a relatively large sample
of psychiatric inpatients who committed HLSA (133 subjects) vs.
psychiatric inpatients who carried out LLSA (299 subjects) and
a control group of psychiatric inpatients who never attempted
suicide (200 subjects).
HLSA were more likely to be males and affected by bipolar
disorder. This is consistent with previous findings showing
that subjects with bipolar disorder presented a higher risk for
attempting and committing suicide (47–49) and supported the
higher lethality suicide among males irrespective from their
psychiatric diagnosis (46, 49–51).
Our study showed that HLSA was clearly associated with
lower total cholesterol and LDL-c, and higher CRP levels when
compared with LLSA and controls. To the best of our knowledge,
no previous studies investigated the association between suicide
lethality and lipid profiles, though our results may be explained
in the light of previous evidence showing that violent methods
to attempt suicide were associated with lower total cholesterol
levels (27).
The well-known cholesterol-serotonin hypothesis (52) may
help to explain these results as lower total cholesterol levels
may foster higher central neuroinflammation, thus altering the
serotonergic system and leading to higher aggressiveness and
impulsivity, especially among males (53). In the central nervous
system, serotonin plays a role in the suppression of aggressive
and harmful behaviors. There are several theories that may
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TABLE 3 | Type of suicide according to lethality.
Total sample
(N = 432)
Suicide Attempt, N (%) 432 (68.4)
High lethality 133 (30.8)
Low lethality 299 (69.2)
TYPE OF SUICIDE ATTEMPT (N = 432), N (%)
Drug intoxication 284 (65.7)
Defenestration 40 (9.3)
Drowning 1 (0.2)
Weapon 2 (0.3)
Stabbing 9 (2.1)
Burn/Gas/Caustic 26 (6.0)
Strangling 11 (2.5)
Cuts 59 (13.7)
explain the potential effect of serum lipid profile (in particular
cholesterol levels) on violent conduct and suicide risk. The
most blamed mechanism is the reduction of brain serotonergic
activity which is associated with the risk of attempting suicide.
It has been hypothesized that cholesterol levels are associated
with the lipid micro viscosity of serotonin receptors and
transporters. Since reliable evidence shows that circulating levels
of cholesterol—those that may be detected by routine blood
tests as those used on the patients in the study—correlate with
the role of stabilizer of cellular membrane functioning (6), and
membrane cholesterol exchanges freely with cholesterol in the
surrounding medium, low membrane cholesterol decreases the
number of serotonergic receptors through the decreased lipid
micro viscosity of the serotonergic receptor on the neuronal
membrane (53, 54). This process could lead to a poorer
suppression of impulsive and violent behaviors, such as suicidal
behaviors (54). As a matter of fact, cholesterol is crucial for
membrane stability and neurotransmission that include the
alteration of membrane lipid raft structure by the proportions
of cholesterol and n-3 PUFAs, affecting the functioning of
membrane-bound proteins including serotonin receptors and
transporters, and toll-like receptors (6, 55). Therefore, low levels
of cholesterol might be responsible of increased n-6:n-3 PUFA
ratio, thereby promoting neuroinflammation as n-3 PUFAs tend
to exert anti-inflammatory properties, while n-6 PUFAs levels
tend to show a pro-inflammatory activity, and disinhibit, albeit
indirectly, two inflammatory intermediates such as nuclear factor
kappa-light-chain-enhancer of activated B cells (NFκB) and
peroxisome proliferator activated receptors (PPARs), respectively
(56). The abnormal monoaminergic neurotransmission as well
as neuroinflammation are two leading mechanisms which are
evoked as biological pathways underlying suicidal behavior (6,
9, 55). Lower cholesterol levels are associated with greater
impulsivity of suicide attempts and violent methods due to their
effects on the serotonergic system. Indirect evidence suggests an
association between attempt lethality and low-cholesterol levels
on the basis of the relation between lethality and the choice of
violent methods to attempt suicide (29).
Although, to the best of our knowledge, no studies
investigated directly the association between CRP, cholesterol,
and cholesterol metabolites serum levels and lethality of suicide
attempts, interestingly, a recent study hypothesized a bridge
between the well-known cholesterol metabolism process with
its associated molecular pathways and the neurobiological
underpinnings of suicide risk, by showing that the relation
between total unesterified cholesterol and suicide risk was
significantly mediated by ABCA-1-specific cholesterol eﬄux
capacity (57).
Conversely, our results show no differences in total cholesterol
and LDL-c levels between LLSA and controls, although ANOVA
did not confirm these findings. The lack of differences concerning
lipid profiles of LLSA and controls could be explained in
the light of the method lethality used to attempt suicide. For
instance, Lalovic et al. (30) reported no significant differences
in cholesterol content between suicide victims and controls in
specific brain regions such as the frontal cortex, amygdala, and
hippocampus. However, when suicides were classified as violent
or non-violent according to the used method, violent suicides
were found to have lower gray-matter cholesterol content in the
frontal cortex compared to non-violent suicides. Other authors
(58), albeit in a small sample, reported no difference in the
levels of total cholesterol and triglycerides among attempters and
non-attempters.
Our findings show that TG were significantly higher in the
control group than in LLSA and HLSA subgroups, among
which no significant differences were reported. This is consistent
with previous studies showing lower TG levels among suicide
attempters when compared with controls without a positive
history of suicide attempts (17, 20–22). Lower TG levels were
reported in subjects who attempted suicide in the month before
the survey compared with subjects who had suicidal ideation in
the month before the survey and never suicidal controls (23).
Moreover, our findings do not show any differences regarding
TG levels in LLSA and HLSA subgroups; to date, no previous
studies investigated the possible association between the lethality
of suicide attempts and TG levels. There are studies in the current
literature that reported no differences in TG levels among violent
vs. non-violent suicide attempts, though they did not consider the
lethality of suicide attempts (25, 59).
Our study should be considered in the light of the following
limitations; firstly, this is a cross-sectional study, and we cannot
assess whether a decrease in TC or TG may have caused a
mood episode with active suicidal ideation leading to suicide
attempts, or if the presence of a mood episode originated a
loss of appetite and a consequent loss of weight altering lipid
profiles. Thus, given the main nature of this study, we could
not evaluate the direct causal relation between suicidal behaviors
and lipid profile. Moreover, our results could not be adjusted
for the psychopharmacological medications that both cases and
controls were taking when assessed and this may have influenced
our findings. However, subjects taking lipid-lowering agents
were not included in the sample. Thirdly, a detailed medical
history, including careful information about the body mass index
(BMI) was not available. Neither blood pressure nor glycaemic
values were collected and, consequently, included in the analysis.
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TABLE 4 | Comparison among three subgroups according to the lethality of suicide attempt.
High lethality
(N = 133)
Low lethality
(N = 299)
Controls
(N = 200)
F p post-hoc
(Bonferroni)
Gender (male), N (%) 51 (38.3) 48 (16.1) 55 (27.5) 26.380 <0.001
Age (years), mean ± SD 49.62 ± 20.69 48.91 ± 19.95 50.89 ± 16.11 0.653 0.521 H=L=C
Education level, mean ± SD 10.93 ± 3.15 11.24 ± 3.32 10.86 ± 3.30 0.963 0.382 H=L=C
MARITAL STATUS, N (%)
Single 62 (46.6) 133 (44.5) 101 (50.5) 5.477 0.484
Married 30 (22.6) 63 (21.0) 38 (19.0)
Divorced 29 (21.8) 69 (23.1) 49 (24.5)
Widowed 12 (9.0) 34 (11.4) 12 (6.0)
Working status, N (%) 36 (27.1) 85 (28.4) 56 (28.0) 0.085 0.959
DIAGNOSIS, N (%)
Bipolar and related disorders 55 (41.4) 87 (29.1) 64 (32.0) 17.603 0.007
Schizophrenia and related disorders 16 (12.0) 21 (7.0) 26 (13.0)
Depressive disorders 41 (30.8) 105 (35.1) 56 (28.0)
Others 21 (15.8) 86 (28.8) 54 (27.0)
Total Cholesterol, mean ± SD 151.08 ± 40.90 184.40 ± 43.21 189.41 ± 33.88 41.921 <0.001 L=C>H
LDL Cholesterol, mean ± SD 99.55 ± 33.25 119.15 ± 38.30 126.15 ± 31.52 23.600 <0.001 L=C>H
HDL Cholesterol, mean ± SD 46.31 ± 17.82 54.64 ± 16.59 50.43 ± 16.50 11.946 <0.001 L>H=C
Triglycerides, mean ± SD 122.13 ± 59.78 110.84 ± 56.03 140.58 ± 86.73 11.480 <0.001 C>H=L
TSH reflex, mean ± SD 2.04 ± 1.89 2.42 ± 1.88 2.40 ± 1.99 1.988 0.138 H=L=C
CRP, mean ± SD 24.18 ± 38.69 8.78 ± 19.66 4.37 ± 5.61 32.808 <0.001 H>L=C
TABLE 5 | Relationship between potential explanatory variables and lethality of suicide attempts: results from the logistic regression analysis.
Step Variables T E.S. Wald df p Exp(B) 95% CI for EXP
Step 1 Gender −0.684 0.274 6.250 1 0.012 0.504 0.295–0.863
Step 2 Diagnosis 0.498 0.252 3.903 1 0.048 1.645 1.004–2.695
Step 3 Total cholesterol −0.022 0.006 15.377 1 <0.001 0.979 0.968–0.989
Step 4 LDL cholesterol 0.004 0.006 0.479 1 0.489 1.004 0.992–1.017
Step 5 HDL cholesterol −0.014 0.008 3.483 1 0.062 0.986 0.971–1.001
Step 6 Triglycerides 0.004 0.002 3.099 1 0.078 1.004 1.000–1.008
Step 7 c-reactive protein—CRP 0.017 0.005 13.844 1 <0.001 1.017 1.008–1.026
Constant 3.388 0.759 19.950 1 <0.001
However, we only included those subjects with stable clinical
conditions apart from what was related to suicide attempts.
CONCLUSIONS
Our data suggest that low total cholesterol serum levels may
increase the risk of HLSA and low triglycerides serum levels
increase suicide risk—as well as low TC levels do—but they
do not influence the lethality of the attempt. To the best
of our knowledge, no previous studies have investigated TC
and TG levels in respect to the lethality of suicide attempt.
Therefore, further studies should focus on this association
in order to confirm these preliminary results and shed
light on the complex neurobiological mechanisms underlying
suicidal behaviors.
AUTHOR CONTRIBUTIONS
AA: supervision data collection, writing protocol, statistical
analyses, writing original draft; PS: writing original draft,
designed the study; GG: writing protocol, conceived, and
designed the study; MC, CC, and MR: data collection, revision
of data literature; EA and MA: review and editing of the original
draft, scientific advisor of the project; GS: designed the study,
review, and editing of the original draft. All authors approved of
the final draft of the manuscript before submission.
Frontiers in Psychiatry | www.frontiersin.org 6 March 2019 | Volume 10 | Article 70
Aguglia et al. Metabolic Parameters and Suicide
REFERENCES
1. World Health Organization. Preventing Suicide: A Global Imperative. Geneva:
World Health Organization (2014).
2. World Health Organization. Global Burden of Disease Geneva: World Health
Organization (2017).
3. Mann JJ, Waternaux C, Haas GL, Malone KM. Toward a clinical model of
suicidal behavior in psychiatric patients. Am J Psychiatry. (1999) 156:181–9.
4. OquendoMA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, SubletteME,
et al. Toward a biosignature for suicide. Am J Psychiatry. (2014) 171:1259–77.
doi: 10.1176/appi.ajp.2014.14020194
5. Pompili M, Longo L, Dominici G, Serafini G, Lamis DA, Sarris J,
et al. Polyunsaturated fatty acids and suicide risk in mood disorders: a
systematic review. Progr NeuroPsychopharmacol Biol Psychiatry (2017) 74:43–
56. doi: 10.1016/j.pnpbp.2016.11.007
6. Daray FM, Mann JJ, Sublette ME. How lipids may affect
risk for suicidal behavior. J Psychiatr Res. (2018) 104:16–23.
doi: 10.1016/j.jpsychires.2018.06.007
7. Loas G, Dalleau E, Lecointe H, Yon V. Relationships between anhedonia,
alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-
reactive protein and serum lipid levels among 122 inpatients with
mood or anxious disorders. Psychiatry Res. (2016) 246:296–302.
doi: 10.1016/j.psychres.2016.09.056
8. Dickerson F, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C,
et al. The association between immune markers and recent suicide attempts
in patients with serious mental illness: a pilot study. Psychiatry Res. (2017)
255:8–12. doi: 10.1016/j.psychres.2017.05.005
9. Sudol K, Mann JJ. Biomarkers of suicide attempt behavior: towards
a biological model of risk. Curr Psychiatry Rep. (2017) 19:31.
doi: 10.1007/s11920-017-0781-y
10. Courtet P, Jaussent I, Genty C, Dupuy AM, Guillaume S,
Ducasse D, et al. Increased CRP levels may be a trait marker of
suicidal attempt. Eur Neuropsychopharmacol. (2015) 25:1824–31.
doi: 10.1016/j.euroneuro.2015.05.003
11. Willour VL, Seifuddin F, Mahon PB, Jancic D, Pirooznia M, Steele J, et al. A
genome-wide association study of attempted suicide. Mol Psychiatry. (2012)
17:433–44. doi: 10.1038/mp.2011.4
12. Pawlak J, Dmitrzak-Weglarz M, Wilkosc M, Szczepankiewicz A, Leszczynska-
Rodziewicz A, Zaremba D, et al. Suicide behavior as a quantitative
trait and its genetic background. J Affect Disord. (2016) 206:241–50.
doi: 10.1016/j.jad.2016.07.029
13. Stanford SM, Bottini M, Bottini N. The role of LMPTP in the metabolic
syndrome. In: Bence KK, editor. Protein Tyrosine Phosphatase Control of
Metabolism. New York, NY; Heidelberg; Dordrecht; London: Springer (2015).
p. 203–20.
14. MuldoonMF,Manuck SB,Matthews KA. Lowering cholesterol concentrations
and mortality: a quantitative review of primary prevention trials. BMJ. (1990)
301:309–14.
15. Lee HJ, Kim YK. Serum lipid levels and suicide attempts.Acta Psychiatr Scand.
(2003) 108:215–21. doi: 10.1034/j.1600-0447.2003.00115.x
16. Fiedorowicz JG, Coryell WH. Cholesterol and suicide attempts: a
prospective study of depressed inpatients. Psychiatry Res. (2007) 152:11–20.
doi: 10.1016/j.psychres.2006.09.003
17. Chang JC, Yen AM, Lee CS, Chen SL, Chiu SY, Fann JC, et al.
Metabolic syndrome and the risk of suicide: a community-based integrated
screening samples cohort study. Psychosom Med. (2013) 75:807–14.
doi: 10.1097/PSY.0000000000000014
18. Aguglia A, Albert U, Maina G. Serum lipids and lifetime suicide attempts
in patients with obsessive-compulsive disorder. J Obsessive Compuls Relat
Disord. (2017) 15:1–6. doi: 10.1016/j.jocrd.2017.07.003
19. Messaoud A, Mensi R, Mrad A, Mhalla A, Azizi I, Amemou B, et al. Is low
total cholesterol levels associated with suicide attempt in depressive patients?
Ann Gen Psychiatry. (2017) 16:20. doi: 10.1186/s12991-017-0144-4
20. Ayesa-Arriola R, Canal Rivero M, Delgado-Alvarado M, Setién-Suero E,
González-Gómez J, Labad J, et al. Low-density lipoprotein cholesterol
and suicidal behaviour in a large sample of first-episode psychosis
patients. World J Biol Psychiatry. (2018) 11:1–4. doi: 10.1080/15622975.2017.
1414305
21. Segoviano-Mendoza M, Cárdenas-de la Cruz M, Salas-Pacheco J, Vázquez-
Alaniz F, La Llave-León O, Castellanos-Juárez F, et al. Hypocholesterolemia
is an independent risk factor for depression disorder and suicide
attempt in Northern Mexican population. BMC Psychiatry. (2018) 18:7.
doi: 10.1186/s12888-018-1596-z
22. Wu S, Ding Y, Wu F, Xie G, Hou J, Mao P. Serum lipid levels and suicidality:
a meta-analysis of 65 epidemiological studies. J Psychiatry Neurosci. (2016)
41:56–69. doi: 10.1503/jpn.150079
23. Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, et al.
Serum lipids, recent suicide attempt and recent suicide status in patients
with major depressive disorder. Progr NeuroPsychopharmacol Biol Psychiatry.
(2014) 51:113–8. doi: 10.1016/j.pnpbp.2014.01.018
24. Ahmadpanah M, Haghighi M, Jahangard L, Borzoei S, Heshmati S, Bajoghli
H, et al. No evidence for metabolic syndrome and lipid profile differences in
patients suffering from bipolar I disorder with and without suicide attempts.
Int J Psych Clin Pract. (2015) 19:168–73. doi: 10.3109/13651501.2015.1049277
25. Bartoli F, Crocamo C, Dakanalis A, Riboldi I, Miotto A, Brosio E,
et al. Association between total serum cholesterol and suicide attempts
in subjects with major depressive disorder: exploring the role of clinical
and biochemical confounding factors. Clin Biochem. (2017) 50:274–8.
doi: 10.1016/j.clinbiochem.2016.11.035
26. Perera S, Eisen RB, Bhatt M, Dennis BB, Bawor M, El-Sheikh W,
et al. Exploring metabolic factors and health behaviors in relation to
suicide attempts: a case-control study. J Affect Disord. (2018) 229:386–95.
doi: 10.1016/j.jad.2017.12.060
27. Alvarez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, et al.
Low serum cholesterol in violent but not in non-violent suicide attempters.
Psychiatry Res. (2000) 95:103–8. doi: 10.1016/S0165-1781(00)00171-2
28. Vevera J, Zukov I, Morcinek T, Papezova H. Cholesterol concentrations in
violent and non-violent women suicide attempters. Eur Psychiatry. (2003)
18:23–7. doi: 10.1016/S0924-9338(02)00011-1
29. Ludwig B, Dwivedi Y. The concept of violent suicide, its underlying trait
and neurobiology: a critical perspective. Eur Neuropsychopharmacol. (2018)
28:243–51. doi: 10.1016/j.euroneuro.2017.12.001
30. Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A,
et al. Cholesterol content in brains of suicide completers. Int J
Neuropsychopharmacol. (2007) 10:159–66. doi: 10.1017/S1461145706006663
31. Freemantle E, Mechawar N, Turecki G. Cholesterol and phospholipids
in frontal cortex and synaptosomes of suicide completers: relationship
with endosomal lipid trafficking genes. J Psychiatr Res. (2013) 47:272–9.
doi: 10.1016/j.jpsychires.2012.10.019
32. American Psychiatric Association.Diagnostic and StatisticalManual of Mental
Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing (2013).
33. Aguglia A, Borsotti A, Cuniberti F, Serafini G, Amore M, Maina G. The
influence of sunlight exposure on hospitalization in emergency psychiatry.
Chronobiol Int. (2017) 34:1413–22. doi: 10.1080/07420528.2017.1374286
34. Aguglia A, Borsotti A, Maina G. Bipolar disorders: is there an influence
of seasonality or photoperiod? Rev Bras Psiquiatr. (2018) 40:6–11.
doi: 10.1590/1516-4446-2016-2144
35. Schrijvers DL, Bollen J, Sabbe BG. The gender paradox in suicidal behavior
and its impact on the suicidal process. J Affect Disord. (2012) 138:19–26.
doi: 10.1016/j.jad.2011.03.050
36. Wu YW, Su YJ, Chen CK. Clinical characteristics, precipitating stressors, and
correlates of lethality among suicide attempters. Chang Gung Med J. (2009)
32:543–52.
37. Shneidman ES. The Suicidal Mind. NewYork, NY: Oxford University Press
(1996). 133 p.
38. Joiner T. Why People Die by Suicide. Cambridge, MA: Harvard University
Press (2007). 37 p.
39. Beautrais AL. Suicides and serious suicide attempts: two populations or one?
Psychol Med. (2001) 31:837–45. doi: 10.1017/S0033291701003889
40. Miller M, Azrael D, Hemenway D. The epidemiology of case fatality
rates for suicide in the northeast. Ann Emerg Med. (2004) 43:723–30.
doi: 10.1016/S0196064404000691
41. Chen VC, Cheng AT, Tan HK, Chen CY, Chen TH, Stewart R, et al. A
community-based study of case fatality proportion among those who carry
out suicide acts. Soc Psychiatry Psychiatr Epidemiol. (2009) 44:1005–11.
doi: 10.1007/s00127-009-0021-9
Frontiers in Psychiatry | www.frontiersin.org 7 March 2019 | Volume 10 | Article 70
Aguglia et al. Metabolic Parameters and Suicide
42. Horesh N, Levi-Belz Y, Apter A. Medically serious versus non-serious
suicide attempts: Relationships of lethality and intent to clinical
and interpersonal characteristics. J Affect Disord. (2012) 136:286–93.
doi: 10.1016/j.jad.2011.11.035
43. Huang YC, Wu YW, Chen CK, Wang LJ. Methods of suicide predict the
risks and method-switching of subsequent suicide attempts: a community
cohort study in Taiwan. Neuropsychiatr Dis Treat. (2014) 10:711–8.
doi: 10.2147/NDT.S61965
44. Lee CY, Wu YW, Chen CK, Wang LJ. The rate of fatality and
demographic characteristics associated with various suicide methods: a
community-based study in Northern Taiwan. Crisis. (2014) 35:245–52.
doi: 10.1027/0227-5910/a000266
45. Trakhtenbrot R, Gvion Y, Levi-Belz Y, Horesh N, Fischel T, Weiser M,
et al. Predictive value of psychological characteristics and suicide history on
medical lethality of suicide attempts: a follow-up study of hospitalized
patients. J Affect Disord. (2016) 199:73–80. doi: 10.1016/j.jad.2016.
03.054
46. Gvion Y, Levi-Belz Y. Serious suicide attempts: systematic review
of psychological risk factors. Front Psychiatry. (2018) 9:56.
doi: 10.3389/fpsyt.2018.00056
47. Schaffer A, Isometsä ET, Azorin JM, Cassidy F, Goldstein T, Rihmer Z, et al. A
review of factors associated with greater likelihood of suicide attempts and
suicide deaths in bipolar disorder: part II of a report of the International
Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust
N Z J Psychiatry. (2015) 49:1006–20. doi: 10.1177/0004867415594428
48. Johnston JAY, Wang F, Liu J, Blond BN, Wallace A, Liu J, et al.
Multimodal neuroimaging of frontolimbic structure and function associated
with suicide attempts in adolescents and young adults with bipolar
disorder. Am J Psychiatry. (2017) 174:667–75. doi: 10.1176/appi.ajp.2016.150
50652
49. Rihmer Z, Gonda X, Döme P. The assessment and management of suicide
risk in bipolar disorder. In: Carvalho F, Vieta E, editors. The Treatment of
Bipolar Disorder: Integrative Clinical Strategies and Future Directions. Oxford:
Oxford University Press (2018) pp. 207–225.
50. Delpozo-Banos M, Hawton K, Gunnel D, Lloyd K, Scourfield J, Dennis
M, et al. CHERISH: understanding suicide clusters through exploring
self harm behaviours. Int J Population Data Sci. (2017) pp. 227–229.
doi: 10.23889/ijpds.v1i1.247
51. Zalsman G, Hawton K, Wasserman D, van Heeringen K, Arensman E,
Sarchiapone M, et al. Evidence-based national suicide prevention taskforce
in Europe: a consensus position paper. Eur Neuropsychopharmacol. (2017)
27:418–21. doi: 10.1016/j.euroneuro.2017.01.012
52. Kaplan JR. Assessing the observed relationship between low cholesterol and
violence-related mortality. Implications for suicide risk. Ann N Y Acad Sci.
(1997) 836:57–80.
53. Tomson-Johanson K, Harro J. Low cholesterol, impulsivity and violence
revisited. Curr Opin Endocrinol Diabetes Obes. (2018) 25:103–7.
doi: 10.1097/MED.0000000000000395
54. Mann JJ. The serotoninergic system inmood disorders and suicidal behaviour.
Phil Trans R Soc B. (2013) 368:20120537. doi: 10.1098/rstb.2012.0537
55. Allen JA, Halverson-Tamboli RA, Rasenick MM. Lipid raft microdomains
and neurotransmitter signalling. Nat Rev Neurosci. (2007) 8:128–40.
doi: 10.1038/nrn2059
56. Liu JJ, Green P, John Mann J, Rapoport SI, Sublette ME. Pathways
of polyunsaturated fatty acid utilization: implications for brain function
in neuropsychiatric health and disease. Brain Res. (2015) 1597:220–46.
doi: 10.1016/j.brainres.2014.11.059
57. Knowles EEM, Curran JE, Meikle PJ, Huynh K, Mathias SR, Goring
HHH, et al. Disentangling the genetic overlap between cholesterol
and suicide risk. Neuropsychopharmacology. (2018) 43:2556–63.
doi: 10.1038/s41386-018-0162-1
58. Pompili M, Innamorati M, Lester D, Girardi P, Tatarelli R. Nearly lethal
resuscitated suicide attempters have no low serum levels of cholesterol and
triglycerides. Psychol Rep. (2010) 106:785–90. doi: 10.2466/PR0.106.3.785-790
59. Da Graça Cantarelli M, Nardin P, Buffon A, Eidt MC, Godoy LA, Fernandes
BS, et al. Serum triglycerides, but not cholesterol or leptin, are decreased in
suicide attempters with mood disorders. J Affect Disord. (2015) 172:403–9.
doi: 10.1016/j.jad.2014.10.033
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Aguglia, Solano, Giacomini, Caprino, Conigliaro, Romano,
Aguglia, Serafini and Amore. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Psychiatry | www.frontiersin.org 8 March 2019 | Volume 10 | Article 70
